Profil
John K.
Cini was the founder of Sonnet BioTherapeutics Holdings, Inc., founded in 2011, where the title held was Chief Scientific Officer from 2020 to 2025.
Dr. Cini is the founder of Sonnet BioTherapeutics, Inc., founded in 2015, holding the title of Chief Scientific Officer starting in 2015.
Former jobs include Executive Director at Medarex, Inc. and Vice President-Discovery & Development Sciences at Outlook Therapeutics, Inc. from 2011 to 2015.
Education includes a doctorate from the University of North Texas.
Aktiva positioner av John Cini
| Företag | Position | Start |
|---|---|---|
Sonnet BioTherapeutics, Inc.
Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology Develops immuno-oncology therapeutics | Grundare | 2015-01-01 |
Tidigare kända positioner av John Cini
| Företag | Position | Slut |
|---|---|---|
| SONNET BIOTHERAPEUTICS | Grundare | 2025-12-02 |
| OUTLOOK THERAPEUTICS, INC. | Företagsledare/Principal | 2015-04-01 |
Medarex, Inc.
Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Direktör/Styrelseledamot | - |
John Cinis utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Medarex, Inc.
Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Health Technology |
University of North Texas
University of North Texas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Outlook Therapeutics, Inc.
Outlook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bevacizumab therapeutic products | Health Technology |
Sonnet BioTherapeutics, Inc.
Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology Develops immuno-oncology therapeutics | Health Technology |
Sonnet BioTherapeutics Holdings, Inc.
Sonnet BioTherapeutics Holdings, Inc. BiotechnologyHealth Technology Develops immuno-oncology therapeutics | Health Technology |
















